Australian University Rankings Guide

Biomarkers in Medicine (ERA Journal)

Biomarkers in Medicine is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Biomarkers in Medicine issns are issn1: 1752-0363 issn2: 1752-0371.

The fields covered by Biomarkers in Medicine as part of the evaluation of Australian university research excellence are:

Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)

Medical Biochemistry and Metabolomics Research Rankings (Sub-Field)

Clinical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:

- Annual Reports in Medicinal Chemistry
- Antiviral Chemistry and Chemotherapy
- ChemMedChem: chemistry enabling drug discovery
- International Journal of Bioscience Biochemistry and Bioinformatics (IJBBB)
- Journal of Cancer Biology and Research
- Journal of Computer-Aided Molecular Design
- Journal of Medicinal Chemistry
- Journal of Peptide Science
- Medicinal Chemistry
- Methods in Molecular Medicine
- Molecular Medicine
- Particle and Fibre Toxicology
- Pharmacology Research and Perspectives
- Tetrahedron: the international journal for the rapid publication of full original research papers and critical reviews in organic chemistr
- eJIFCC - electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4